INMODE LTD IS -01 (154) - Total Liabilities
Based on the latest financial reports, INMODE LTD IS -01 (154) has total liabilities worth €89.58 Million EUR (≈ $104.73 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of INMODE LTD IS -01 to track the company's year-over-year net asset growth rate.
INMODE LTD IS -01 - Total Liabilities Trend (2022–2025)
This chart illustrates how INMODE LTD IS -01's total liabilities have evolved over time, based on quarterly financial data. See INMODE LTD IS -01 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
INMODE LTD IS -01 Competitors by Total Liabilities
The table below lists competitors of INMODE LTD IS -01 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Gold Royalty Corp.
NYSE MKT:GROY
|
USA | $180.52 Million |
|
Dilip Buildcon Limited
NSE:DBL
|
India | Rs144.99 Billion |
|
Advanced Wireless Semiconductor Co
TWO:8086
|
Taiwan | NT$2.29 Billion |
|
Hubei Biocause Heilen Pharmaceutical Co. Ltd.
SHE:301211
|
China | CN¥117.63 Million |
|
Shandong New Beiyang Information Technology Co Ltd
SHE:002376
|
China | CN¥2.02 Billion |
|
Transcat Inc
NASDAQ:TRNS
|
USA | $176.12 Million |
|
Max Estates Limited
NSE:MAXESTATES
|
India | Rs92.76 Billion |
|
Ashapura Minechem Limited
NSE:ASHAPURMIN
|
India | Rs30.53 Billion |
Liability Composition Analysis (2022–2025)
This chart breaks down INMODE LTD IS -01's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see INMODE LTD IS -01 (154) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 8.80 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how INMODE LTD IS -01's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for INMODE LTD IS -01 (2022–2025)
The table below shows the annual total liabilities of INMODE LTD IS -01 from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €83.23 Million ≈ $97.31 Million |
+1.68% |
| 2024-12-31 | €81.85 Million ≈ $95.70 Million |
+7.82% |
| 2023-12-31 | €75.91 Million ≈ $88.75 Million |
-15.45% |
| 2022-12-31 | €89.79 Million ≈ $104.98 Million |
-- |
About INMODE LTD IS -01
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous ski… Read more